Dr. Hao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Rose Street
Lexington, KY 40536Phone+1 859-323-7507Fax+1 859-257-7715
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2007 - 2010
Atrium Health Navicent The Medical Center/Mercer University School of MedicineResidency, Internal Medicine, 2004 - 2007- OtherClass of 1986
Certifications & Licensure
KY State Medical License 2017 - 2025
GA State Medical License 2009 - 2019- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Pembrolizumab + Idelalisib for Lung Cancer Study Start of enrollment: 2017 Sep 26
Publications & Presentations
PubMed
- 4 citationsDescription of a Lung Cancer Hotspot: Disparities in Lung Cancer Histology, Incidence, and Survival in Kentucky and Appalachian Kentucky.Christine Fillmore Brainson, Bin Huang, Quan Chen, Laurie E. McLouth, Chunyan He
Clinical Lung Cancer. 2021-03-26 - 56 citationsLenvatinib in Management of Solid Tumors.Zhonglin Hao, Peng Wang
The Oncologist. 2020-02-01 - 60 citationsNovel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1.Mingqiang Ren, Mei Hong, Gentao Liu, Hongjin Wang, Vijay Patel
Oncology Reports. 2013-06-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
